Cyclacel Pharmaceuticals, Inc.
| 2013 | FY |
Year ended
December 31,
2013
Preferred shares exchanged
877,869
Common shares issued:
At stated convertible option
53,366
Incremental shares issued under the exchange transaction
1,631,105
Total common shares issued
1,684,471
us-gaap:ScheduleOfConversionsOfStockTextBlock